Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.26.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DS.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.15 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.348EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.575EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.4 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.442EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.1 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.600EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.12 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.525 (Eta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.6 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.7 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.24 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.45 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.70 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.26.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.108 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used